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INFERENCE ON CENSORED SURVIVAL DATA UNDER COMPETING
RISKS
Jeong Youn Lim , PhD
University of Pittsburgh, 2012
Competing risks is commonly encountered in survival data. While fundamental methods
have been established to analyze survival data in the presence of competing risks, some of
methods still remain undeveloped. The primary goal of this study is to extend existing
methods for survival analysis to the competing risks settings.
In the first study is to determine the optimal cutpoint in the presence of competing risks.
A continuous variable often needs to be dichotomized to quantify the prognostic effect. The
“outcome-oriented” cutpoint approach is the useful method without any prior knowledge
about that variable, which is to seek an optimal cut point that provides the maximum
difference in prognostic effect between the splits. The rescaled sequential method is one of
the approaches for estimating the optimal cutpoint and for adjusting its significance after
the dichotomization. We adapted the concept of improper random variables from Gray’s
test and modified log-rank test to apply the rescaled sequential approaches. We present
simulation results of the operating characteristics of the proposed method. A real dataset
from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 is exemplified.
In the second part, a quantile residual life regression model was developed for competing
risks. Residual life analysis provides useful information when the effect of prognostic factors
on the distribution of remaining lifetimes is evaluated at several years after the initial diag-
nosis/therapy. This model allows for meaningful interpretations of covariate effects on not
only any quantile residual life but also at a specific time point. Simulation studies are per-
formed to assess the finite sample properties of proposed method in terms of the parameter
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estimator, type I error and power of the test statistics at different time points. The new
regression method is illustrated with a NSABP B-04 dataset.
Although competing risks have been an important issue in survival analysis research,
it is often neglected by clinical researchers due to its complex nature and lack of available
methodology. Development of inference procedures suitable for competing risks data would
provide more accurate additional information, which has great significance in a public health
perspective leading to improved patient care in clinical settings.
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1.0 INTRODUCTION
1.1 SURVIVAL ANALYSIS
In many biomedical studies an outcome of interest is a time from a pre-defined origin to
occurrence of particular event such as disease or death. One distinguishing feature of this
time-to-event data is censoring, which is the case when the event does not occur within the
study duration and its distribution is assumed to be independent of event time. Special
statistical techniques to analyze those data have been widely developed and commonly ac-
cepted in the medical literature. Without assumption about underlying distribution of the
data, the Kaplan-Meier estimator (Kaplan and Meier, 1958) [18] is the standard estimator
of the survival function. This is a step function with jumps at the observed event times,
t1 < t2 < ...tD, taking into account of censored observations, formulated as
Sˆ(t) =
∏
ti≤t
(
1− di
Yi
)
, (1.1)
where di is number of events and Yi is number of subjects at risk at time ti. Kaplan-Meier
curve plotting survival function by time might be a first step for a preliminary evaluation
of survival rate. Typically it provides a graphical visual comparison on the survival rate
between grouped patients, for instance, treatment and placebo. To test hypotheses about
the equality in the survival distribution of two or more groups, log-rank test (Peto, 1972)
[23] is commonly used. The log-rank statistic can be calculated by computing the sum of
the differences between observed and expected events in one of the group at the observed
times, that is,
U =
∑(
d1i − Y1i di
Yi
)
(1.2)
1
where d1i and d2i are the numbers of events in group 1 and group 2, respectively, and Y1i
and Y2i are the numbers of subject at risk at time ti, respectively, then di = d1i + d2i and
Yi = Y1i+Y2i in two group comparison. To regress survival time on related prognostic factors,
the Cox-proportional hazard regression is one of popular and unique regression techniques
(Cox, 1972) [5]. It can be presented with baseline hazard h0(t) and covariate term exp(β
′X)
as
h(t|X) = h0(t) exp(β′X) (1.3)
Equation (1.3) implies that if X = 0, a baseline hazard is observed. Furthermore, the two
hazard functions are portional. Those are some of the established methodologies for survival
data, which is assumed only one type of event of interest.
1.2 COMPETING RISKS
In many cases in survival data, multiple types of event could exist and actually they “com-
pete” with each other, but we generally observe only one event whichever occurs first. We
call this as a competing risks data. Typically, competing risks can be defined as a situation
where any other types of events preclude the occurrence of our primary event or modify
the probability of it [11]. In a cancer treatment clinical trial, relapse of disease and death
is a well known example of competing risks. Cancer patients could die due to any other
reason without relapse and this occurrence is a competing risks event that prevents the can-
cer relapse from happening. Another example can be found in a radiation trial where local
recurrence is the primary event of interest, and then distance recurrence is a competing risks
event that affects the probability of local recurrence.
In a competing risks setting, unlike regular survival data, subjects would have event of
interest, competing risks event, or censored, at the end of study as illustrated in Figure 1,
and the analysis approach will be different depending on the goal and hypothesis of the
study. In a cancer treatment clinical trial, if investigators focus on the treatment effect in
“disease-free survival”, it can be analyzed by standard survival method. Whereas, if the
primary interest is in the treatment effect in relapse of disease, death become a competing
2
Figure 1: A schematic illustrating survival (top) and competing risks (bottom) data
risks event and standard survival analysis considering death as independent censoring leads
to biased results [24]. To analyze survival data with multiple types of event, the time to
event need to be defined carefully, and competing risks event should be identified.
It has been suggested by many authors that the cumulative incidence function is the
appropriate descriptive quantity under competing risks. The cumulative incidence function
(CIF), a joint density function of the specific event type can be defined
Fk(t) = P (T ≤ t,  = k) =
∫ t
0
hk(u) exp{−HT (u)}du =
∫ t
0
hk(u)S(u)du (1.4)
where hk(t) is a cause specific hazard rate and HT (t) =
∑K
k=1
∫ t
0
hk(u)du is the sum of K
cause-specific cumulative hazard rates. Note that the cumulative incidence function depends
on not only hazard rate of event type of interest but also the hazard rate of other type of
events. This leads to more suitable interpretation that the probability of failure from type k
by time t where all other competing events may influence on individual. Whereas, the com-
plement of the Kaplan-Meier (1 - KM) estimator is a naive approach which is often misused
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to estimate the cumulative probability of event of interest in the presence of competing risks
event. 1 - KM estimate of cumulative incidence of event type k can be denoted as Gk(t),
Gk(t) =
∫ t
0
hk(u) exp{−
∫ t
0
hk(u)}du =
∫ t
0
hk(u)Sk(u)du. (1.5)
It tends to overestimate the probability of failure of specific type of event, ignoring the
competing risks. This can be explained simply by the fact that Sk(u) > S(u), and Gk(t) >
Fk(t) in (1.4) and (1.5) . Figure 2 compares the 1 - KM and cumulative incidence function
estimates of the breast cancer related death in the presence of the other types of events of
B-04 data, from National Surgical Adjuvant and Bowel Project (NSABP). The amount of
overestimation of 1 - KM increases with time.
Gray’s test (Gray,1988) [12] and Fine & Gray’s subdistribution proportional hazards
regression (Fine and Gray, 1999) [7] analogous to log-rank test and Cox proportional hazards
model, are known defined methods to account for competing risks. In this study, we revisit
Gray and log-rank test statistics for comparison under competing risks and propose a simple
modified log-rank test statistic to determine the optimal cutpoint of a continuous risk factors,
in the presence of competing risks. Secondly,the quantile residual life regression is developed
for competing risks data. The regression model was built based on the conditional cause-
specific quantile residual life defined from the cause-specific residual cumulative incidence
function. This technique allows for alternative nonparametric inference with meaningful
interpretations of covariate effects.
4
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2.0 DETERMINATION OF OPTIMAL CUTPOINT IN COMPETING
RISKS
2.1 INTRODUCTION
Although dichotomizing a continuous variable has some drawbacks, such as a loss of infor-
mation and power (Royston et al., 2006) [26], it is a commonly used method for investigators
not only to be free of the linearity assumption but also to quantify the prognostic effects,
providing more straightforward interpretation. For instance, in breast cancer clinical trial
studies, it is well known that recurrence and estrogen receptor level are highly correlated. A
patient with higher estrogen receptor level is more likely to recur breast cancer. Investiga-
tors might want to dichotomize this value to quantify the prognostic effect, such as relative
risk. However, it is not simple to determine the optimal cut point to split the continu-
ous variable without biological reasoning or prior information. “Data-oriented” cut point,
such as median, mean or quantile is frequently used but it is simply because there is no
prior information regarding the optimal cut point. A more systematic “outcome-oriented”
approach has been considered to select the cut point that leads to maximum difference in ef-
fect. Contal and O’Quigley (1999) [4] proposed a method to estimate the optimal cut point
and its significance, constructing a statistic that asymptotically follows Brownian bridge.
Their application was in survival data, thus the optimal cutpoint is chosen that corresponds
to the maximum value of the process based on the log-rank test. However, in cancer clinical
studies, when reccurence of disease is the event of interest, then other types of event, such
as other types of cancer or death often occur prior to the recurrence. We need to take those
competing risks events into account to determine the optimal cutpoint. the log-rank test
(Peto, 1972) [23] is used to compare the cause-specific hazard functions after censoring all
6
uninteresting events. It assumes that the specific risk is the only risk acting on the pop-
ulation. Thus it could cause inaccurate results to use log-rank test under competing risks
data. Gray’s method (Gray,1988) [12], one of the most popularly used in competing risk
data, compares the subdistribution hazards taking account of uninteresting events.
In this chapter, we propose a modified log-rank test using the notion of the improper
random variable from Gray’s test. This way, the log-rank can be applied to the Contal and
O’Quigley method improving the accuracy to estimate optimal cutpoint and it’s significance
in competing risks data. Simulation studies were carried out to assess the performance of
proposed method and it is applied to clinical trail data from NSABP B-14.
2.2 BACKGROUND
2.2.1 Cutpoint Model in Survival Analysis
Let Z be a continuous covariate and T be the outcome, namely time to event in survival
data then (Zi, Ti), i = 1..n is paired observations. One approach to investigating relationship
between Z and T is that to split population into two groups; those who have the variable
Z smaller than certain cutpoint µ, and those who have the variable Z larger than µ and to
test the null hypothesis below
H0 : Pr(T ≤ t|Z ≤ µ) = Pr(T ≤ t|Z > µ). (2.1)
Without the prior information, the choice of the cutpoint, µ is generally based on the max-
imization of a measure of difference between the groups, which is called “outcome-oriented”
method. In survival analysis, the cutpoint can be estimated based on Cox proportional
hazards model
h(t|Z, µ) = h0(t) exp{βµ I [X ≤ µ]} (2.2)
testing the null hypothesis that H0 : βµ = 0. The point that corresponds to maximize the
test statistic (e.g., likelihood-ratio test, Wald test, and score test) or to minimize the p-value
of the test among the possible observed Zi will be the optimal cutpoint. However, since we
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have picked the cutpoint that gives the most significant result after multiple testings, it tends
to overestimate the significance of the difference based on obtained cutoff values (Miller and
Siegmund, 1982) [20]. There has been several approaches to addressing this issue to make
inference about βµ.
Jesperson (1986) [15] used the score statistics to construct a new test statistic WJ defined
by
WJ =
supµ |U(0, µ)|√
D
, (2.3)
where U(0, µ) is the score test statistic and D is the number of events. Using counting
process theory, Jespersen showed that this test statistic WJ under the null has a limiting
distribution of sup |W 0(p)|, 0 ≤ p ≤ 1, where W 0(p) is a Brownian Bridge. Using distribution
of sup |W 0(p)| below formula given in Billingsley (1968) [3], Jespersen’s adjusted p-value and
critical values of the test can be obtained.
P
(
sup
0≤p≤1
|W 0(p)| ≥ k
)
= 2
( ∞∑
j=1
(−1)j+1 exp(−2j2k2)
)
(2.4)
Lausen and Schumacher (1992, 1996) [19] proposed a method to correct the minimum
p-value of the test. It is generalization of theoretical approach of Miller and Siegmund
(Miller and Siegmund, 1982) [20] that maximally selected χ2 statistic in 2 × 2 tables is the
distribution of the supremum of the absolute value of a standardized Brownian Bridge,
sup
p∈[,1−]
|W 0(p)|√
p(1− p) (2.5)
with 0 <  < 0.5 and p = Fz(Z) where Fz(Z) denote the distribution of Z, and the following
approximation for the distribution
P
(
sup
p∈[,1−]
|W 0(p)|√
p(1− p) > b
)
∼= φ(b)
(
b− 1
b
)
ln
(
(1− )2
2
)
+ 4
(
φ(b)
b
)
(2.6)
Lausen and Schumacher restricted the range of the hypothetical cutpoint, [Z(n), Z(n(1−))]
where Zk is the kth order continuous variable, Zi and 0 <  < 0.5. They showed that the
maximally selected standardized test statistic converges to the supremum of the absolute
value of a standardized Brownian Bridge,
Max{|C(µ)|, µ ∈ [Z(n), Zn(1−)]} D→ sup
p∈[,1−]
|W 0(p)|√
p(1− p) , as n→∞. (2.7)
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and use the Miller and Siegmund approximation to obtained corrected p-value. Let Pmin be
the smallest p-value among those p-value from the test based on all hypothetical cutpoints,
µ, over the range
[
Z(n), Zn(1−)
]
. Then p-value can be adjusted by
Pcor = φ(w)
(
w − 1
w
)
ln
(
(1− )2
2
)
+ 4
φ(w)
w
, (2.8)
where w = φ−1(1 − Pmin/2) with φ(w) is the standard normal density. Their corrected p-
value approach has been recommended and applied by many studies, but the arbitrariness
and inconsistency depends on the choice of  can be a limitation.
A third method is a rescaled sequential approach proposed by Contal and O’Quigley
(1999) [4]. This method is based on the Billingsley (1968) [3] following result. If the αi
are exchangeable random variables and satisfy the three following conditions, that is called
Noether condition:
n∑
i=1
αi
p→ 0,
n∑
i=1
α2i
p→ 1, max
1≤i≤n
|αi| p→ 0, as n→∞, (2.9)
then Sn(p) =
∑[np]
i=1 αi converges in distribution to the Brownian Bridge, W
0(p) in (2.4) where
0 ≤ p ≤ 1 and [.] is the greatest integer function. The scores of log-rank test statistic are
exchangeable random variable, and then standardized form of the score is also exchangeable
and meet the Noether condition. When the observed event, D is equal to total sample size
n, the log-rank test is equal to Savage’s test, which is a linear rank statistic with exponential
scores defined by
ai = 1−
i∑
j=1
1
D − j + 1 (2.10)
with var(a)= {1/(D − 1)}∑Dj=1 a2j . The process Sn(p) can be constructed by
Sn(p) =
1√
var(a)(D − 1)
D∑
i=1
ai. (2.11)
and it follows Brownian bridge asymptotically. The censoring case, D ≤ n, log-rank statistics
is used and normalized by var(a). Wu (2001) [31] examined and compared those method
with extensive simulation study and suggested that rescaled sequential approach performs
more powerful and robust in censoring case. Our extension to estimate the optimal cutpoint
in the presence of competing risks will follow the rescaled sequential approach.
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2.2.2 Comparison of Test Statistic
In this section we will review the test statistic to compare the survival rate under competing
risks. First, log-rank test is the most commonly used test in survival data to compare the
hazard rates between groups. However, when it comes to competing risks setting, it compares
the cause-specific hazard after censoring other types of events of no interest at the time of
occurrence . Let  = 1, ..., K be the type of event then type k specific hazard is
hk(t) = lim
δt→0
{
P (t < T ≤ t+ δt,  = k|T > t)
δt
}
. (2.12)
Let t1 < t2 < · · · < tD be the distinct death times in the pooled sample and dij be the
number of an interesting event and Yij be the numbers at risk in group j at time ti, i =
1, ..., D, j = 1, ...J . Let di and Yi be the corresponding numbers for combined groups at time
ti. Then the log-rank test is the form of
Zj(τ) =
D∑
i=1
Wj(ti)
{
dij
Yij
− di
Yi
}
, j = 1, . . . , J (2.13)
In general, weight function is the form of Wj(ti) = YijL(ti), and when L(ti) = 1, it simplifies
Zj(τ) =
D∑
i=1
{
dij − Yij
(
di
Yi
)}
, j = 1, . . . , J (2.14)
On the other hand, Gray’s method compares subdistributions of cause-specific events
among different groups in competing risks data. The subdistribution, also called cumulative
incidence function [17], Fk(t) = Pr(T ≤ t,  = k), is a joint probability of observing event
type k in the presence of other types of events. Gray defined it as Fk(t) = Pr(T
∗
k ≤ t) using
the improper random variable, T ∗k = I( = k) × T + I( 6= k) ×∞. He pointed out that
the relationship of cause specific hazards is different from that of cumulative incidence in
competing risks setting. That is, even though cause specific hazard for type 1 in group 1 is
higher than that for type 1 in group 2, the cumulative incidence for group 2 could be higher
than that for group 1 at some point. His method is based on weighted averages of the hazard
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of the subdistribution functions for the event of interest, k. Let’s assume that there is only
two type of events (K=2) and the general form of score for group j is
Ujk(τ) =
∫ τ
0
Wjk(t) {γjk(t)− γ0k(t)} dt, j = 1, . . . , J. (2.15)
Where γjk(t) is the hazard of the subdistribution for group j, and γ0k(t) is the hazard of the
subdistribution for all groups together of our interesting type of event, where hazard of the
subdistribution can be defined
γk(t) = lim
δt→0
{
P (t < T ≤ t+ δt,  = k|T > t ∪ (T ≤ t ∩  6= k)
δt
}
. (2.16)
Without loss of generality, let’s assume only two types of events: event of interest and
competing event. The test is refer to the event of interest, the index for the type of event
will be suppressed. The weight function (Gray,1988) is the form Wj(t) = Rj(t)L(t) and
Rj(t) can be estimated
Rj(t) = Yj(t)
1− Fˆj(t−)
Sˆj(t−)
(2.17)
Where Yj(t) is number of individuals at risk at time t in group j, Fj(t−) is the left-hand
limit of the cumulative incidence function for the event of interest in group j and Sj(t−) is
the left-hand limit of the probability of being free of any event in group j, as estimated by
the Kaplan-Meier method. When only event of interest occurs then Sj(t−) = 1 − Fj(t−),
but once competing risks event occurs, Sj(t−) < 1− Fj(t−) and the difference will increase
as more competing risks events happen. That is, we can say that Rj is the estimated number
of individuals at risk adjusted by the number of competing risks event happened.
For simplicity, we present when J = 2, and L(t) = 1 in the discrete case. Then,
Ri1 = Yi1
1− Fˆ1(ti−1)
Sˆ1(ti−1)
(2.18)
and the score is
11
Z∗1 =
D∑
i=1
W1(ti)
{
di1
Ri1
− di1 + di2
Ri1 +Ri2
}
(2.19)
=
D∑
i=1
{
di1 −Ri1
(
di1 + di2
Ri1 +Ri2
)}
where W1(ti) = Ri1.
This is similar to the form of the log-rank test, except the risk set (denominator) adjusted
by the number of event of competing risk already occurred up to time ti.
2.3 PROPOSED METHOD
2.3.1 Modified Log-rank Test
To find the optimal cutpoint in competing risks, we introduce a modified log-rank test
statistic by directly applying the improper random variable concept to the observed dataset
rather than estimating the risk process. An improper random variable can be defined by
setting time to event of competing risks as infinity. That is, the event of competing risks is
considered as the censoring at the end of the study, always being included in the risk set.
Let rij be the number of events of competing risks up to time ti in jth group and ri be the
corresponding numbers for combined groups. Modified log rank test with improper random
variable can be derived in the same way as the ordinal log rank test, by adding the number
of competing risks event to a risk set by directly applying the improper random variable
concept to the observed dataset rather than estimating the risk process. Improper random
variable can be defined by setting time to event of competing risks as infinity. That is the
event of competing risks is considered as the censoring at the end of the study, always being
included in the risk set. Let rij is the number of events of competing risks up to time ti in
jth group and ri is the corresponding numbers for combined groups. Modified log rank test
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with improper random variable can be derived in the same way as the ordinal log rank test,
by adding the number of competing risks event to a risk set
Z∗j =
D∑
i=1
Wj(ti)
{
dij
Yij + rij
− di
Yi + ri
}
, j = 1, . . . , J, (2.20)
where the weight function, Wj(ti) = (Yij + rij)L(t) is the same form as above. The variance
and covariance can be derived using that dij follow the hypergeometric distribution with
parameter di and Pj = (Yij + rij)/(Yi + ri), j = 1, . . . , J.
The variance of Z∗j is
σ̂jj =
D∑
i=1
(
Yij + rij
Yi + ri
)(
1− Yij + rij
Yi + ri
)(
Yi + ri − di
Yi + ri − 1
)
di, j = 1, . . . , J (2.21)
and the covariance of Z∗j , Z
∗
g is given by
σ̂jg = −
D∑
i=1
(
Yij + rij
Yi + ri
)(
Yig + rig
Yi + ri
)(
Yi + ri − di
Yi + ri − 1
)
di, g 6= j (2.22)
The test statistic is given by the quadratic form with estimated variance-covariance matrix,
Σ(J−1)×(J−1).
(Z1(τ), . . . , Zj−1(τ))Σ−1(Z1(τ), . . . , Zj−1(τ))t (2.23)
When the null hypothesis is true, this statistic follow a chi-square distribution, with J − 1
degree of freedom. When J = 2 the test statistics can be expressed by
Z =
∑D
i=1 di1 − (Yi1 + ri1)
(
di
Yi+ri
)
√∑D
i=1
(
Yi1+ri1
Yi+ri
)(
1− Yi1+ri1
Yi+ri
)(
Yi+ri−di
Yi+ri−1
)
di
(2.24)
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2.3.2 Estimation Procedure
The re-scaled sequential estimation procedure described in Contal and O’Quigley (1999) [4]
was applied to our modified log-rank statistic. Let t1, . . . , tD be the ordered observed death
time and for µk be the hypothetical cutpoint of continuous covariate Z, then the number for
log-rank statistic at each failure time can be summarized in D2×2 tables below.
Died Survived + Competing events total
Z ≤ µk d	i Y 	i + r	i − d	i Y 	i + r	i
Z ≥ µk d⊕i Y ⊕i + r⊕i − d⊕i Y ⊕i + r⊕i
Total di Yi + ri − di Yi + ri
Where di is the number of event of interest at time ti, Yi is the number of individual at risk
just before ti and ri is the number of competing events up to ti. For a fixed cutpoint µk, the
modified log-rank statistic based on the groups defined by being less(	) than or greater(⊕)
than µk can be computed as
Sk =
D∑
i=1
[
d⊕i − di
Y ⊕i + r
⊕
i
Yi + ri
]
. (2.25)
The estimated cut point µˆ is the value of µk which corresponds to the maximum |Sk|, and
the adjusted test statistic for testing any difference between the splits by the optimal cut
point is
Q =
max|Sk|
s
√
D − 1 , (2.26)
where s is defined by
s2 =
1
D − 1
D∑
i=1
{
1−
i∑
j=1
1
D − j + 1
}2
. (2.27)
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2.4 SIMULATION
We carried out a Monte Carlo simulation to assess the properties of our proposed test
statistic and the behavior of the estimated cutpoint based on this statistic. For simplicity, we
considered only two types of competing events, type 1 events being of our interest. Failure
time of type 1, T1i, was assumed to follow a Weibull distribution with survival function
S(t) = exp(−ρtκ), where ρ and κ are scale and shape parameters, respectively. Failure time
of type 2, T2i, was assumed to follow a unit exponential distribution for all groups. The true
improper subdistribution function for type 1 event can be specified as,
F1(t) = pi {1− exp(−ρtκ)} ⇔ Pr(T ≤ t,  = 1) = Pr( = 1) Pr(T ≤ t| = 1),
To simulate the data set, first we generate  from a Bernoulli distribution with success
probability of pi, then conditioning on the  value, generate an event time from the proper
Weibull distribution F1(t)/pi with ρ1 for group 1 and ρ2 for group 2. In Figure 3, the
estimated cumulative incidence curves (Gray, 1988) [12] were plotted using the R function
cuminc and compared with the true subdistribution functions.
The first set of simulation is to examine the size of the test and to compare the pow-
ers of the tests using different values of κ, hazard ratio between two split groups and the
probability of each type of failure, pi. Their distribution for failure type 1 is F
(1)
1 (t) =
1/2 {1− exp(−ρ1tκ)} for group 1, and F (2)1 (t) = 1/2 {1− exp(−ρ2tκ)} for group 2, so that
ρ2/ρ1 will be the hazard ratio between two groups. The independent censoring times Ci were
generated from a uniform and exponential distribution with constant c which controls the
censoring proportion. With a fixed total sample size of n=500, simulations were performed
for various combinations: 0% to 30% censoring proportions, ρ1 = 0.1, ρ2 = 0.1 to 0.4 to make
the hazard ratio of 1 through 4, κ = 1, 2 and pi = 0.5, 0.6, 0.7. The results indicate that
empirical size is close to the true nominal level of 5% when the hazard ratio (hr) equal to 1
as shown in Table 1. The power increses with the larger hazard ratio and success probability
of type 1 event when the κ is equal to 1(Table 2) and 2 (Table 3).
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Figure 3: Estimated cumulative incidence curves of simulated data (solid line) and true
subdistribution (dotted line) where type 1 event time is from Weibull distribution (ρ1 =
0.1, ρ2 = 0.2) and type 2 event time is from unit exponential distribution
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Table 1: Empirical sizes of a nominal 5% level test for different pi(0.5, 0.6, 0.7), κ(1, 2) and
censoring proportion with n = 500
κ = 1 κ = 2
c% pi=0.5 pi=0.6 pi=0.7 pi=0.5 pi=0.6 pi=0.7
0 4.2 5.1 4.8 5.2 5.0 4.8
10 3.1 4.8 4.4 5.8 4.5 5.3
20 4.3 4.4 4.4 5.5 5.0 4.5
30 4.7 5.6 4.7 5.7 4.8 4.0
Table 2: Empirical powers for different pi(0.5, 0.6, 0.7), hr(2, 3, 4) and censoring proportion
with κ = 1 and n = 500
pi=0.5 pi=0.6 pi=0.7
c% hr 2 3 4 2 3 4 2 3 4
0 17.5 32.3 42.7 29.8 54.8 69.2 49.4 81.9 93.0
10 41.0 68.5 82.3 45.9 85.2 93.7 69.8 95.9 99.6
20 56.9 92.4 98.4 65.9 91.8 99.2 79.5 99.0 99.9
30 66.9 95.8 99.5 74.3 98.1 100 85.5 99.7 100
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Table 3: Empirical powers for different pi(0.5, 0.6, 0.7) and hr(2, 3, 4) and censoring propor-
tion with κ = 2 and n = 500
pi=0.5 pi=0.6 pi=0.7
c% hr 2 3 4 2 3 4 2 3 4
0 17.1 32.0 41.7 28.1 52.9 69.2 49.3 81.7 93.0
10 23.5 44.1 61.2 36.9 68.0 83.1 54.2 86.6 99.6
20 29.5 55.7 75.2 45.3 77,6 92.0 57.8 89.9 99.9
30 35.1 67.0 84.7 49.7 93.7 95.3 59.8 94.0 100
The test statistic Q (2.26) has a limiting distribution of the supremum of the absolute
value of a Brownian Bridge under the null hypothesis. In next simulation, we examine the
distribution of Q under H0. In accordance with the Cox proportional hazard model (Cox,
1972) [5], the outcome variable Ti was generated from F
(1)
1 (t) or F
(2)
1 (t) depending on whether
the continuous prognostic effect Z (unit uniform distribution) is greater (group 1) or less
(group 2) than hypothetical cutpoint at µ = 0.5. Figure 4 presents the simulated relative
frequency of the maximum value of the statistic set of potential cutpoints under the null
hypothesis (ρ.1 = ρ.2 = 0.1) with different sample sizes (n = 100, 200, 300), and κ = 1, 2.
The asymptotic values for the test statistic provide a good approximation for the Brownian
bridge.
The simulated distributions of the estimated cutpoint with various effect, exp(β) in the
proportional Cox hazards model are represented in Figure 5. The simulation model has a
true cutpoint at 25th (0.25) and 50th (0.5) percentile of Z, which follows uniform distribution
with sample size n = 200, κ = 1((a),(c)), 2 ((b),(c)), with 30% censoring. As ρ.2 values has
various values (1 4, 6, 8), hazard ratio changes from 1 to 4, 6 and 8. We extend the same
simulation in the case that Z follows the standard normal distribution with true cut point at
−0.67 and 0 in Figure 6. We observe that the larger the hazard ratio, the smaller confidence
interval of µˆ, as expected.
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Figure 4: Upper part of the simulated distribution of the extremum value of the standardized
process under the null hypothesis
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Figure 5: Distribution of the simulated cutpoint estimator where κ = 1 ((a),(c)), κ = 2
((b),(c)) the true cutpoint is equal to 0.5 ((a),(b)) and 0.25 ((c),(d)) under Uniform Z.
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Figure 6: Distribution of the simulated cutpoint estimator under Normal Z.
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Table 4: Estimated Cutpoint of AGE
Placebo (n=1450) Treatment (n=1435)
Mean 54.6 54.9
Median 56 56
Range 25-71 25-75
Selection Interval 31-70 33-70
Estimate, µˆ 41 47
P-value 0.05 0.26
2.5 EXAMPLE
A dataset from National Surgical Adjuvant Breast and Bowel Project (NSABP) trial, Pro-
tocol B-14, was used to illustrate our proposed method. In this phase III trial, over a 6-year
period, patients with primary breast cancer, negative axillary lymph nodes, and estrogen
receptor positive tumors were randomized to receive either tamoxifen (n = 1453) or placebo
(n = 1439) following surgery and has been followed more than 20 years. The event of interest
(type 1) was local-regional recurrence as first event, while all other events such as distant
recurrences, other types of cancer, or death prior to any disease were considered to be com-
peting events (type 2). In this dataset, our continuous prognostic variables (Z) of interest
are age and estrogen receptor level. Outer 1% of the distribution in each side was excluded,
thus the potential cutpoints are those within inner 98% of the distribution. We estimated
the cutpoint which maximized the absolute value of proposed log-rank statistics under com-
peting risks among the potential cutpoints. Table 3 and Table 4 surmmarize the result. The
estimated optimal cutpoint of age is 41 in tamoxifen group and 47 point in placebo group.
The adjusted p-value shows that the age effect is significant on survival for placebo group
but not for treatment group. For estrogen recepter level, the estimated cutpoint was 610 in
tamoxifen group and 580 in placebo group. Age effect was not significant in neither groups.
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Table 5: Estimated Cutpoint of Estrogen Receptor Level (fm/mole)
Placebo (n=1449) Treatment (n=1435)
Mean 1213.7 1178.1
Median 580 610
Range 0-15910 0-31870
Selection Interval 100-9760 100-7800
Estimate, µˆ 185 415
P-value > 0.3 0.16
2.6 SUMMARY
In medical research, dichotomizing continuous variables based on a cutpoint is a common
strategy to quantifying the prognostic factors. In some situations, however, a cutpoint of
continuous measurement is not obvious. Recent increasing study of using biomarker is one
instance that is required a cut-point to dichotomize a biomarker level but none of definite
point exist. Much of effort has been done to analyze competing risk data, not much attention
has been drawn to determine the optimal cutpoint in a continuous variable under competing
risks. Here we proposed a modified log-rank test, adapting the notion of improper random
variable from Gray’s test by adding the number of competing events to risk sets rather
than estimating it. This way it can be applied to the method of Contal and O’Quigley
(1999) [4], preserving the properties of the log-rank statistic. Simulation results indicate the
adequacy of our method using proposed statistics and it was applied to a real dataset, B-14
to estimating a optimal cutpoint of age and estrogen receptor level and adjusted p-value by
treatment status in the presence of competing risks.
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3.0 COMPETING RISKS QUANTILE RESIDUAL LIFE REGRESSION
3.1 INTRODUCTION
Residual life analysis provides useful information when the effect of prognostic factors on
the distribution of remaining lifetimes is evaluated at several years after the initial diagno-
sis/therapy. For instance, in a long-term breast cancer clinical trial where the secondary
therapy being considered for patients who remain recurrence free after the initial treatment,
the residual life analysis would provide a straightforward prediction of a patient’s lifetime
that could be prolonged by the new therapy. However, the residual life regression has not
been studied in the competing risks setting commonly encountered in medical data. In this
study we propose competing risks quantile residual life regression model based on the condi-
tional cause-specific quantile residual life defined from the cause-specific residual cumulative
incidence function. We describe the estimation procedure to obtain the parameter estimates
and test statistic which does not require estimation of the variance-covariance matrix of the
regression estimators. This model provides meaningful interpretations of covariate effects
on not only any quantile residual life but also at a specific time point. Simulation studies
are performed to assess the finite sample properties of proposed method in terms of the
parameter estimator, type I error and power of the test statistics at different time point.
In addition, new regression method is illustrated with a real dataset protocol B-04 from a
breast cancer clinical trial that was performed by the National Surgical Adjuvant Breast and
Bowel Project (NSABP).
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3.2 BACKGROUND
3.2.1 Quantile Residual Life Function (Median Residual Life Function)
As mean and median are commonly used statistical measurement to summarize the distribu-
tion of the data, mean residual life (MRL) function and median residual life (MERL) function
are useful function to describe the remaining life time in survival data. Although MRL func-
tion has been of much interest in the actuarial science, survival studies and reliability theory,
MERL function has several advantages over MRL function especially when data are censored
or has fat-tailed distribution (Schmittlein and Morris,1981) [27]. A more general concept of
MERL function is a α-quantile residual life function θ(α)(t) = α − quantile(T − t|T > t),
that is a α quantile of remaining life times among survivals beyond time t can be presented
as followings.
P
{
T − t > θ(α)(t)|T > t} = 1− α
P
{
T > t+ θ(α)(t)
}
= (1− α)P (T > t)
S
{
t+ θ(α)(t)
}
= (1− α)S(t)
MERL function has been extensively studied by many authors. Wang and Hettmansperger
(1990) [29] introduced a confidence interval approach to compare two quantiles from failure
time distributions under censoring and Su and Wei (1993) introduced a nonparametric test
statistic to improve Wang and Hettmansperger’s procedure by using the minimum dispersion
statistic (Basawa and Koul, 1988) [1]. Berger, Boos and Guess (1982) [2] proposed a modified
test statistic based on Fligner and Rust’s approach (1982) [9] to compare two median residual
life times under censoring, which involves a nonparametric estimation of the pdf of the failure
time distribution under censoring. Jeong, Jung and Costantino (2008) [14] extended Su and
Wei’s method to compare median residual lifetime at any fixed time point during the follow-
up period.
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3.2.2 Regression on Quantile Residual Life
There has been a few studies in regression model for the residual life function. Rao, Dama-
raju, and Alhumoud (1993) [25] inferred the covariate effects on the quantile residual life
function under the parametric accelerated failure time (AFT) and Cox proportional hazard
models. Regression model for the simple median originally introduced by Ying, Jung and
Wei(1995) [32]. It is a semiparametric approach to examine the covariate effects on median
survival, analog to AFT model, alternative to traditional Cox proportional hazard. As the
AFT model regresses the logarithm of the survival time on its covariates, they regress the
median of failure time on the covariates. Unlike AFT model that relates the mean of the
logarithm of the failure time to the covariates, it linearly relates the median of failure time.
Gelfand and Kottas (2003) [10] modeled the median residual life function induced by the
AFT assumption under the Bayesian framework. Jung, Jeong and Bandos (2009) [16] re-
cently developed a semiparametric regression method on a quantile residual life to assess
the effect of covariates at a given time point. This is a generalized form of Ying’s (1995)
[32] method to time-specific quantile regression, where the quantile residual function can be
modeled at any specific time point. They consider a linear regression model for a τ -quantile
of residual lifetimes at time t0, on a log-scale,
τ − quantile{log(Ti − t0)|Ti ≥ t0, Zi} = βτ |t0Zi (3.1)
This model specifies a linear relationship between the τ -quantile residual lifetime on a log-
scale and the vector of covariates at a specific time t0. The special type of estimating equation
which is modification of least absolute deviations(LAD) method is used to estimate for βτ |t0 .
Let Ti and Ci denote failure and censoring time for ith patient and Yi = min(Ti, Ci). Without
censoring, the LAD estimate can be obtained by minimizing
∑n
i=1 |log(Ti − t0)− βτ |t0Zi|,
which is equivalent to solving the equation
Un(βτ |t0) =
n∑
i=1
Zi[I{Ti ≥ t0 + exp(βτ |t0Zi)}] = 0. (3.2)
For censored case, where Yi is observed survival time and Gˆ is the Kaplan-Meier estimate
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of the survival function of the censoring distribution, the estimating equation is following.
Sτ |t0,n(βτ |t0) =
n∑
i=1
Zi
[
I{Yi ≥ t0 + exp(βτ |t0Zi)}
Gˆ{t0 + exp(βτ |t0Zi)}
− (1− τ)I(Yi ≥ t0)
Gˆ(t0)
]
= 0 (3.3)
Due to the discontinuity of the function Sτ |t0,n(βτ |t0), the estimating equation does not
always have an exact solution, therefore, an estimator βˆτ |t0 is defined as a minimizer of the
Euclidean norm of the function
∥∥Sτ |t0,n(βτ |t0)∥∥. To test the null hypothesis H0 : βτ |t0 = βτ |t0,0,
they use the estimating function Sτ |t0,n(βτ |t0) directly, without estimating covariance matrix
depending on the unknown density function.
3.2.3 Cause-Specific Quantile Residual Life Function
Residual life analysis has been introduced in the competing risks setting, with multiple and
potentially dependent failure types (Jeong and Fine 2009) [13]. We previously described that
the cumulative incidence function correctly quantifies the proportion of the event of interest
in the presence of competing risks. They brought the “residual” concept into cumulative
incidence function and defined the residual cumulative incidence function for all-cause,
Ft0 = Pr(T − t0 ≤ t|T > t0) = {S(t0)− S(t+ t0)}/ S(t0), t > 0 (3.4)
and extended this to the cause specific residual cumulative incidence function to quantify
the residual cumulative probability of event of interest, considering the existence of the
competing risks.
Fk,t0 = Pr(T − t0 ≤ t,  = k|T > t0) = {Fk(t+ t0)− Fk(t0)}/ S(t0), t > t0 (3.5)
Inverting this function, a τ -th quantile of event of interest(k) residual life distribution,
Qk,t0(τ) was defined, that is Qk,t0(τ) = inf{q : Fk,t0(q) ≥ τ}, τ < Fk,t0(∞). For the case
t0 = 0, Qk,t0 is identical to Qk in Peng & Find (2007) [21] based on Fk. Assuming Fk,t0
is absolutely continuous and it’s derivative, fk,t0 is positive around Qk,t0 , then Qk,t0(τ) can
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be estimated with nonparametric estimate of Fˆk(.) and Kaplan-Meier estimator Sˆ(.) for all
causes.
uˆ{Qk,t0(τ)} = Fˆk{t0 +Qk,t0(τ)} − Fˆk(t0)− τ Sˆ(t0) = 0, (3.6)
Nonparametric inference was performed without estimation of fk,t0 . To test the null
hypothesis, H0 : Qk,t0(τ) = q, the statistic T (q) = n{Fˆk,t0(q) − τ}2/σˆ2{Qˆk,t0(τ)} which
follows χ21 distribution was used and inverted to construct a confidence interval.
3.3 PROPOSED METHOD
3.3.1 Estimation Procedure
Let Yi, i = 1, 2, ..., n, denote the minimum of the failure time Ti and censoring time Ci. Let
i be the cause of failure and δi = I(Ti ≤ Ci)i. Without covariates, we denote Fk,t0(t)
for the cause-specific residual cumulative incidence function (CIF) for type k events at time
t0 and Qk,t0(τ) for the corresponding cause-specific quantile residual life function (Jeong
and Fine, 2009) [13]. Given a vector of covariates Z, we similarly define Qk,t0(τ |Z) =
inf {t : Fk,t0(t|Z) ≥ τ} (k = 1, ..., K). Without loss of generality, it will be assumed that
there are only two types of competing events, so that δi = 0, 1, or 2, type 1 events being
of primary interest. Note that the associated cause-specific residual cumulative incidence
function given survival up to t0 can be defined as
F1,t0(t|Z) = Pr(T − t0 ≤ t, i = 1|T > t0, Z)
= {F1(t+ t0|Z)− F1(t0|Z)} /S(t0|Z), t > t0 (3.7)
where F1(·) is the cause-specific CIF for type 1 events and S(·) is the all-cause survival
function. Defining Q1,t0(τ |Z) as the τ th quantile of the residual life distribution of type 1
events at a given time t0, we have
u {Q1,t0(τ |Z)} = F1 {t0 +Q1,t0(τ |Z)|Z} − F1(t0|Z)− τS(t0|Z) = 0. (3.8)
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We propose a regression model that assumes the log-linear relationship between Q1,t0(τ) and
a covariate vector, i.e. Q1,t0(τ |Z) = exp(β′1,t0|τZ), where β1,t0|τ is a (p+ 1)× 1 vector of the
regression coefficients, and Z is a (p + 1) × 1 vector of covariates. Then the equation (3.8)
implies
Pr(Ti ≤ t0 + exp(β′1,t0|τZi), i = 1|Zi)− Pr(Ti ≤ t0, i = 1|Zi) = τPr(Ti ≥ t0|Zi). (3.9)
Assuming conditional independence between (Ti, i) and Ci given Z (Peng and Fine, 2009)
[22], the first term of the left hand side of equation (3.9) is equivalent to
E
{
I(Yi ≤ t0 + exp(β′1,t0|τZi), δi = 1)
G(Yi|Zi)
∣∣∣Zi} (3.10)
= E
[
E
{
I(Ti ≤ t0 + exp(β′1,t0|τZi), i = 1, Ci ≥ Ti)
G(Ti|Zi)
∣∣Ti, i, Zi}∣∣∣Zi]
= E
[
I(Ti ≤ t0 + exp(β′1,t0|τZi),  = 1)G(Ti|Zi)
G(Ti|Zi)
∣∣∣Zi]
= Pr(Ti ≤ t0 + exp(β′1,t0|τZi), i = 1
∣∣Zi)
where G(·) is the survival function of the censoring distribution. Similarly, the second term
of the left hand side in equation (3.9) has the following equivalence:
Pr(Ti ≤ t0, i = 1|Zi) = E
{
I(Yi ≤ t0, δi = 1)
G(Yi|Zi)
∣∣∣Zi} .
Therefore the equation (3.9) can be reexpressed as
E

[
I{Yi ≤ t0 + exp(β′1,t0|τZi)} − I(Yi ≤ t0)
]
I(δi = 1)
G(Yi|Zi)
∣∣∣Zi
 = E {τ I(Yi ≥ t0)
G(t0|Zi)
∣∣∣Zi} ,
(3.11)
which leads to an estimating equation for the regression parameter β1,t0|τ ,
S1,t0|τ,n(β1,t0|τ ) = 0, (3.12)
where
S1,t0|τ,n(β1,t0|τ ) =
n∑
i=1
Zi

[
I
{
Yi ≤ t0 + exp(β′1,t0|τZi)
}
− I(Yi ≤ t0)
]
I(δi = 1)
Gˆ(Yi|Zi)
− τ I(Yi ≥ t0)
Gˆ(t0|Zi)

(3.13)
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where Gˆ(·|Z) is the Kaplan-Meier estimator of the conditional censoring distribution given
covariates. However, throughout this study, we will assume that the censoring distribution
is independent of the covariates since in a well-designed clinical trial, important prognostic
factors are balanced across the treatment groups, featured with administrative censoring.
Due to the discontinuity of S1,t0|τ,n(β1,t0|τ ), the estimating equation would not always
have the exact solution, thus a solution βˆ1,t0|τ is defined as a minimizer of the function,
Euclidean norm ||S1,t0|τ,n(β1,t0|τ )||, defined as the square root of sum of squares. For opti-
mization, we use a grid search method to minimize an ||S1,t0|τ,n(β1,t0|τ )||. Following is the
iterative algorithm to obtain the solution, supposing β1,t0|τ is the 2-dimensional parameter
case.
step1: Based on initial value (x0, y0), initial region [x0 ± a]× [y0 ± b] are given
step2: Compute ||S(.)|| with all intersected points of equi-distance grid within initial
region
step3: Obtain S(1) which has a minimum ||S(.)|| and set the corresponding (xi, yi)
as a second initial value
step4: Consider the equi-distance grid within [x0 ± 0.75 ∗ a]× [y0 ± 0.75 ∗ b] region
step5: Obtain S(2) which has a minimum ||S(.)|| among the intersected points within
second grid
step6: Iterate step2 - step5 until S(1) − S(2) < 0.001 and corresponding(xj, yj) of S(2) is
the solution (βˆ0, βˆ1).
3.3.2 Test Statistics
As Jeong and Fine (2009) noted, the asymptotic variance of the quantile estimator would
involve the probability density function of the failure time distribution under censoring,
which is improper under competing risks. Since our model assumes the log-linear relationship
Q1,t0(τ |Z) = exp(β′1,t0|τZ), evaluation of the asymptotic variance of the test statistic for the
null hypothesis H0 : β1,t0|τ = β1,t0|τ,0 would also involve estimation of the probability density
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function. To avoid it, we will form our test statistic based on the estimating equation
S1,t0|τ (β1,t0|τ ) directly, as in Su and Wei (1993) [28]. We have shown, in the Appendix
B, that the distribution n−1/2S1,t0|τ,n(β
0
1,t0|τ ) is approximately normal with mean zero and
variance-covariance matrix Γ1,t0|τ = n
−1∑n
i=1 ξ1,t0|τ,i ξ
′
1,t0|τ,i, where
ξ1,t0|τ,i =
[
{I(Yi ≤ t0 + exp(βˆ1,t0|τZi))− I(Yi ≤ t0)}I(δi = 1)
G(Yi)
− τ I(Yi ≥ t0)
G(t0)
]
Zi
+
∫ ∞
−∞
G−1(s)
∫ s
−∞
h−1(v){dI(Yi ≤ v, δi = 0)− I(Yi ≥ v)dΛG(v)}dq1(s)
−q2(t0)
∫ t0
−∞
h−1(s){dI(Yi ≤ s, δi = 0)− I(Yi ≥ s)dΛG(s)},
where ΛG(.) is the cumulative hazard function for the censoring variable,
q1(s) = lim
n→∞
n−1
n∑
i=1
Zi
[
I(t0 + exp(β
0′
1,t0|τZi)) ≥ min(s, Yi)− I(t0 ≥ min(s, Yi))
]
I(δi = 1),
q2(t0) = limn→∞(τ/n)G(t0)−1
∑n
i=1 I(Yi ≥ t0)Zi, and h(v) = limn→∞
∑n
i=1 I(Yi ≥ v)/n.
Here ξ1,t0|τ,i can be consistently estimated by
ξˆ1,t0|τ,i =

[
I{Yi ≤ t0 + exp(βˆ′1,t0|τZi)} − I(Yi ≤ t0)
]
I(δi = 1)
Gˆ(Yi)
− τ I(Yi ≥ t0)
Gˆ(t0)
Zi
+
n∑
l=1
Zl
[
I{Yl ≤ t0 + exp(βˆ′1,t0|τZl)} − I(Yl ≤ t0)
]
I(δl = 1)
Gˆ(Yl)

I(δi = 0)I{Yi ≤ t0 + exp(βˆ′1,t0|τZl)}∑n
m=1 I(Ym ≥ Yi)
−
n∑
j=1
I(δj = 0)I
[
Yj ≤ min{t0 + exp(βˆ′1,t0|τZl), Yj}
]
∑n
m=1 I(Ym ≥ Yj)2

−
n∑
l=1
{
Zl
τI(Yl ≥ t0)
nGˆ(t0)
}[
I(δi = 0)I(Yi ≤ t0)∑n
m=1 I(Ym ≥ Yi)
−
n∑
j=1
I(δj = 0)I{Yj ≤ min(t0, Yi)}∑n
m=1 I(Ym ≥ Yj)}2
]
.
Denoting Γˆ1,t0|τ for the consistent estimator of Γ1,t0|τ , the test statistic
n−1S ′1,t0|τ,n(β1,t0|τ,0)Γˆ
−1
1,t0|τS1,t0|τ,n(β1,t0|τ,0), (3.14)
asymptotically follows a χ2-distribution with p + 1 degrees of freedom. A large observed
value of this statistic would result in rejection of the null hypothesis.
31
Now suppose that we are interested in a local test for a subset of the regression coeffi-
cients. Given a partition of the regression coefficients, β1,t0|τ = (β
(1)
1,t0|τ
′
, β
(2)
1,t0|τ
′
), where β
(1)
1,t0|τ
is a r × 1 vector, let us consider testing the null hypothesis of H0 : β(1)1,t0|τ = β
(1)
1,t0|τ,0. To
eliminate the subset of the nuisance parameters β
(2)
1,t0|τ , we form a variation of the minimum
dispersion statistic (Basawa and Koul, 1988) [1],
V (β
(1)
1,t0|τ,0) = min
β
(2)
1,t0|τ
{n−1S1,t0|τ,n((β(1)1,t0|τ,0
′
, β
(2)
1,t0|τ
′
)) Γˆ−11,t0|τ S1,t0|τ,n((β
(1)
1,t0|τ,0
′
, β
(2)
1,t0|τ
′
))}. (3.15)
Following the arguments in Wei et al.(1990) [30] (Appendix 2) and Ying et al. (1995)
[32] (APPENDIX C), it can be shown that the statistic V (β
(1)
1,t0|τ,0) has approximately a
χ2-distribution with r degrees of freedom.
3.4 SIMULATION
We have performed numerical studies to evaluate the finite sample properties of our estimator
and test statistic, based on the median residual regression, τ = 0.5. For simplicity, we assume
two type of competing events, and type 1 events being of our interest. A simple regression
model with one binary covariate x(1) is considered as follows:
Q1,t0 = exp(β
(0)
1,t0
+ β
(1)
1,t0
x(1)). (3.16)
Failure time Ti was assumed to follow a Weibull distribution with survival function
S(t) = exp{−(ρt)κ}. When pi is the probability of type 1 event, the cumulative incidence
functions for type 1 and type 2 events can be expressed as F1(t) = pi{1 − exp{−(ρ1t)κ1}}
and F2(t) = (1−pi){1−exp{−(ρ2t)κ2}}, respectively. Under the hypothesis of H˜0 : β(1)1,t0 = 0,
the median residual for type 1 event distribution is given by
Q1,t0 = exp(β
(0)
1,t0
) = F−11 {τS(t0) + F1(t0)} − t0
= (1/ρ1) [−log{1− {τS(t0) + F1(t0)}/pi}]1/κ − t0, t0 ≥ 0. (3.17)
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At the origin of time (t0 = 0), Q1,0 = (1/ρ1) [−log{1− {τS(0) + F1(0)}/pi}]1/κ and then ρ1
can be determined as
ρ1 =
[−log{1− {τS(0) + F1(0)}/pi}]1/κ
Q1,0
=
{−log(1− τ
pi
)}1/κ
exp(β
(0)
1,0)
(3.18)
where S(0) = 1 and F1(0) = 0. Now assuming ρ2 = 0.4, κ1 = κ2 = 1.5 and exp(β
(0)
1,0) = 5,
event times were generated from Ti1 = (1/ρ1){−log(1 − ui)}1/κ1 for type 1 and from Ti2 =
(1/ρ2){−log(1−ui)}1/κ2 for type 2 in both comparison groups using the probability integral
transformation where ui ∼ UNIF(0, 1). Censoring times Ci were from UNIF(0, c), where c
is a constant that controls for the censoring proportion. The observed survival times were
determined by Yi = min(Ti, Ci), where Ti = (Ti1, Ti2)
′.
The first part of simulation is to evaluate the empirical distribution of regression pa-
rameter estimates at different time points in terms of mean (median) and standard error
(SE) at different time points for the censoring proportions of 0%, 10%, and 20%. Under
H˜0 : β
(1)
1,t0
= 0, from equation (3.17) the true parameter value of β
(0)
1,t0
is obtained as 1.61,
1.40, 1.18 and 0.98 at t0 = 0, 1, 2 and 3. The grid search algorithm described in the previous
section was used with initial value of (1.6, 0) and ranges a = b = 5 to find the minimizer of
the estimating equation (3.12). With sample size of 200, 1000 simulations were performed.
Table 5 presents the result that the mean (median) values of the estimates of parameters
are close to their true values for earlier time points, but the bias and SE tend to increase at
later time points. This was expected due to loss of information as time progresses in terms
of the number of type 1 events. Next, we examine the type I error probabilities and power
for testing the null hypothesis H˜0 : β
(1)
1,t0
= 0. In Table 6, when the true value of β
(1)
1,t0
is 0,
one can observe that the type I error probabilities tend to be conservative at the nominal
level of 0.05. This is similar to the results presented in Ying et al.(1995) [32], and Jung et
al.(2009) [16]. Table 5 also summarizes the probabilities power of rejecting the null hypoth-
esis when the true parameter values are β
(1)
1,t0
= 0.18, 0.69, and 1.03, respectively. Those
values correspond to the differences in median residual lifetime of type 1 events between two
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groups being 1, 5, and 9 at t0 = 0. As expected, power increases with larger β
(1)
1,t0
values and
decreases with higher censoring proportions.
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Table 6: Mean (Median) and standard error (SE) of empirical estimates of the true regression
parameters β
(0)
1,t0
= 1.61, 1.40, 1.18, 0.98 at t0 = 0, 1, 2, 3 with β
(1)
1,t0
= 0 and the total number
of observation (n) is 200
t0 c% β
(0)
1,t0
SE β
(1)
1,t0
SE
0 0 1.640(1.602) 0.295 -0.041(0.006) 0.418
10 1.661(1.616) 0.265 -0.075(-0.014) 0.382
20 1.675(1.624) 0.279 -0.092(-0.035) 0.400
1 0 1.386(1.375) 0.259 0.032(0.033) 0.402
10 1.426(1.398) 0.254 -0.044(-0.010) 0.366
20 1.437(1.396) 0.272 -0.063(-0.023) 0.404
2 0 1.139(1.147) 0.315 0.058(0.0334) 0.475
10 1.176(1.168) 0.384 -0.021(-0.010) 0.515
20 1.187(1.174) 0.451 -0.042(-0.024) 0.598
3 0 0.874(0.919) 0.792 0.114(0.063) 1.025
10 0.866(0.945) 1.054 0.082(0.010) 1.233
20 0.838(0.961) 1.267 0.096(-0.002) 1.487
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Table 7: Type 1 error probabilities and power for testing the null hypothesis H0 : β
(1)
1,t0
=
0(t0 = 0, 1, 2) where the true values are β
(1)
1,0 = 0 (type I error), 0.18, 0.67, 1.03 (power) and
the total sample size (n) is 200
β
(1)
1,t0
0 0.18 0.69 1.03
t0 = 0 c% = 0 0.032 0.12 0.90 0.98
10 0.026 0.07 0.54 0.83
20 0.022 0.04 0.46 0.83
1 0 0.022 0.10 0.89 0.99
10 0.023 0.08 0.64 0.78
20 0.022 0.05 0.53 0.74
2 0 0.034 0.10 0.84 0.99
10 0.025 0.07 0.73 0.71
20 0.021 0.05 0.60 0.61
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3.5 EXAMPLE
The B-04 study performed by National Surgical Adjuvant Breast and Bowel Project (NS-
ABP) was a phase III randomized clinical trial on breast cancer to compare the effect of
traditional radical mastectomy and less aggressive total mastectomy on patient’s survival
with or without additional radiation therapy. In this study, a total of 1079 women with
clinically negative axillary nodes and 586 women with clinically positive axillary nodes were
were assigned to one of treatment groups. After long-term follow-up over 30 years (Fisher et
al,2002) [8], about 90% of all pateints were either followed or died and also about 30% among
node-negative patients and about 20% among node-positive patients were censored. Death
following breast cancer recurrence (type 1 events) and non-breast-cancer related death (type
2 events) were considered as competing events. In this section, we reanalyze the B-04 data
to assess the effect of important prognostic factors on the quantile residual lifetime of the
distribution of breast-cancer related deaths.
First, we consider a simple regression model with only one covariate of nodal status,
xnode coded as 0 or 1 for node-negative and node-positive. Figure 7 shows the estimated
cause-specific residual cumulative incidence for breast cancer related death at different time
points. It is clear from the plots that the most estimates does not exceed 0.5, so that we
regress on lower quantiles (τ = 0.1, 0.2, 0.3) rather than the median. Parameters β
(intercept )
1,t0|τ
and β
(node)
1,t0|τ are estimated at different time points, t0 = 0, 2, 4, 6, 8. Based on those estimates,
the τ -percentile residual lifetime for node-negative and node-positive were obtained from
Qˆ
(	)
1,t0
(τ) = exp(βˆ
(intercept)
1,t0|τ ) and Qˆ
(⊕)
1,t0
(τ) = exp(βˆ
(intercept)
1,t0|τ + βˆ
(node)
1,t0|τ ). Those values were illus-
trated graphically denoting the smallest value at which the estimated residual cumulative
incidence for breast cancer related death crosses τ as shown in Figure 8 when τ = 0.3 and
t0 = 0. To confirm that our parameter estimates are reasonable, we compared ours with the
estimates from Jeong and Fine (2009) [13] that were evaluated separately for node-negative
and node-positive patients. Table 7 summarizes the parameter estimates, which indicates
that our regression estimates are comparable to ones from Jeong and Fine (2009).
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(d) at time=6
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Figure 7: Residual cumulative incidence estimates for breast cancer related death at different
time points (t0 = 0, 2, 4, 6) in B-04
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(a) Q(0.3) estimate for node positive at time=0
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(b) Q(0.3) estimate for node negative at time=0
Figure 8: Graphical demonstration of residual Life for (a) node-positive and (b) node-
negative with τ=0.3 at t0 = 0
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Table 8: Simple regression model; regression parameter estimates and various quantile resid-
ual life estimates (0.1, 0.2, 0.3) at different time points (t0 = 0, 2, 4, 6, 8) with a single covariate
(nodal status)
Estimates via Regression Jeong & Fine
τ t0 βˆ
(intercept )
1,t0|τ βˆ
(node)
1,t0|τ Qˆ
(	)
1,t0
(τ) Qˆ
(⊕)
1,t0
(τ) Qˆ
(	)
1,t0
(τ) Qˆ
(⊕)
1,t0
(τ)
0.1 0 0.98 -0.70 2.66 1.32 2.72 1.28
2 0.65 -0.58 1.91 1.07 1.95 1.04
4 0.98 -0.53 2.65 1.57 2.63 1.73
6 1.37 -1.31 3.92 1.06 3.96 1.04
8 1.56 -0.84 4.77 2.05 4.92 2.17
0.2 0 1.66 -0.80 5.24 2.36 5.26 2.36
2 1.57 -0.55 4.81 2.77 4.81 2.76
4 2.05 -0.90 7.75 3.17 7.87 3.16
6 2.29 -1.20 9.83 2.96 9.99 2.98
8 2.45 -0.56 11.60 6.60 11.80 6.57
0.3 0 2.35 -0.96 10.53 4.04 10.53 4.07
2 2.45 -0.84 11.57 4.99 11.45 4.98
4 2.79 -0.09 16.31 5.49 16.03 5.63
6 3.19 -1.19 24.24 7.39 21.41 6.77
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Secondly, we fit the proposed model to adjust for additional important covariates such
as age at diagnosis of breast cancer and pathological tumor size along with the node-status
to predict percentile residual lifetimes for breast-cancer-related death at any follow-up time
point. A multiple regression model was constructed with Z = (1, Xnode, Xage, Xtsize) where
Xage and Xtsize were included as continuous covariates after rescaled by multiplying by 0.01
just for computational convenience. Table 8 shows the estimated regression parameters and
corresponding p-values. At the bottom of Table 8, for a comparison we also present p-
values from the subdistribution hazard regression model ([7]), which compares the average
subdistribution hazards under the proportionality assumption. As expected, nodal status
and tumor size had negative effect on the quantile residual lifetimes for breast-cancer-related
death, at all time points considered. This implies that patients with positive nodes and larger
tumor size at the diagnosis tend to live shorter than ones with the opposite characteristics,
no matter what follow-up time point they were evaluated. Interestingly, however, age at
diagnosis of breast cancer shows positive effects at earlier time points, but the effects become
negative in later time points, while the Fine & Gray model indicates the average negative
effect of age in subdistribution hazard rate. This might imply that breast cancers developed
in younger patients (possibly genetic effect) are known to be more aggressive, so that they
tend to die earlier due to breast cancer, but patients who have overcome the “high-risk”
period (about 2 years) would have longer life expectancy than ones whose diseases were
developed at older ages (possibly age effect).
To verify the tendency of age effect over time on breast cancer related death, we re-
analyzed NSABP B-14 data with age at diagnosis of breast cancer and pathological tumor
size as covariates. This data have relatively lower cumulative incidence rate with higher
censoring proportion (58%) shown in Figure 9, thus only lower percentile of τ = 0.1, 0.2 were
considered. Table 9 summarized the estimated regression parameters and corresponding p-
values along with the results from subdistribution hazard regression model (Fine & Gray,
1999) for comparison. We confirm the coherent tendency of age effect on breast cancer
related death in that it has positive effects at earlier time points but become negative at
time=6 when τ = 0.2.
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Table 9: Multiple regression model; regression parameter estimates for different quantiles
(0.1, 0.2, and 0.3) at different time points (t0 = 0, 2, 4, 6, 8) with multiple covariates (nodal
status, age, tumor size) and associated p-values with B-04
τ t0 βˆ
(intercept)
1,t0|τ p-value βˆ
(node)
1,t0|τ p-value βˆ
(age)
1,t0|τ p-value βˆ
(tsize)
1,t0|τ p-value
0.1 0 1.11 <0.0001 -0.67 <0.0001 0.78 0.010 -1.56 <0.0001
2 0.20 0.286 -0.41 0.296 1.85 0.067 -1.89 0.008
4 0.93 0.145 -0.44 0.103 0.79 0.554 -1.49 0.147
6 1.80 <0.0001 -1.27 <0.0001 0.10 0.748 -1.51 0.063
8 2.61 0.005 -0.93 0.001 -1.51 0.289 -0.42 0.374
0.2 0 1.02 <0.0001 -0.56 <0.0001 2.14 0.003 -1.63 <0.0001
2 0.74 0.004 -0.44 0.004 2.49 0.007 -1.63 0.0003
4 3.77 <0.0001 -0.71 <0.0001 -1.89 0.838 -2.04 0.026
6 3.54 <0.0001 -1.20 <0.0001 -1.08 0.075 -1.64 0.002
8 6.76 <0.0001 -1.07 0.005 -5.70 0.005 -2.24 0.019
0.3 0 1.97 <0.0001 -0.77 <0.0001 1.75 0.0009 -1.81 <0.0001
2 3.18 <0.0001 -0.79 <0.0001 -0.02 0.048 -2.11 <0.0001
4 4.09 <0.0001 -1.09 <0.0001 -0.92 0.189 -1.92 <0.0001
Fine and Gray model 0.54 <0.0001 -1.04 0.0008 0.78 <0.0001
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(c) at time=4
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Figure 9: Residual cumulative incidence estimates for breast cancer related death at different
time points (t0 = 0, 2, 4, 6) in B-14
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Table 10: Multiple regression model; regression parameter estimates for different quantiles
(0.1, 0.2) at different time points (t0 = 0, 2, 4, 6, 8) with multiple covariates (age, tumor size)
and associated p-values with B-14
τ t0 βˆ
(intercept)
1,t0|τ p-value βˆ
(age)
1,t0|τ p-value βˆ
(tsize)
1,t0|τ p-value
0.1 0 1.51 0.02 1.80 0.02 -2.51 <0.0001
2 1.81 0.14 1.34 0.14 -3.75 <0.0001
4 1.25 0.09 1.92 0.08 -2.70 <0.0001
6 1.69 0.38 1.32 0.42 -2.94 0.0004
8 1.95 0.59 1.03 0.59 -2.35 0.03
0.2 0 3.14 0.05 0.49 0.06 -3.11 <0.0001
2 3.12 0.04 0.89 0.17 -4.52 0.0008
4 3.27 0.37 0.25 0.79 -3.02 0.09
6 5.08 0.67 -1.51 0.51 -4.87 0.38
Fine and Gray model -0.73 0.084 1.89 <0.0001
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3.6 SUMMARY
Competing risks is often encountered in medical research with multiple failure types. We pro-
posed a regression model to associate the quantile residual lifetime with important covariates
at a given time point under a competing risks setting. A vector of covariates was regressed
on the conditional cause-specific quantile residual life function, which can be obtained by
inverting the cause-specific residual cumulative incidence function. We constructed the esti-
mating equation for the regression coefficients and a test statistic to evaluate the covariate
effects. Asymptotic distributions of the regression parameter estimator and test statistic
have been derived. Simulation studies show that the proposed test procedure has reasonable
finite sample properties in type I error probabilities and powers. A real dataset from the
NSABP B-04 study was reanalyzed for the quantiles of τ = 0.1, 0.2, 0.3 at given follow-up
years. The grid search method was used for optimization in our simulation studies and real
data example. The proposed model can be a useful alternative to the subdistribution pro-
portional hazard model by providing more detailed and clinically more relevant information
of covariate effects on the life expectancy.
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4.0 DISCUSSION
In clinical research, patients/subjects could have more than one types of outcomes including
the primary event of interest and other events, because in reality they are exposed to multiple
risk factors that might possibly be correlated. The primary goal of this study was to extend
existing methods for survival analysis to the competing risks settings.
First study was initially motivated from the need to relate the prognostic effect to di-
chotomized status of biomarker in cancer clinical trials where competing risks are often
encounter. To determine the optimal cutpoint in competing risks setting, we simply mod-
ified the log-rank test using the notion of the improper random variable from Gray’s test
[12]. This enables us to modify the Contal and O’Quigely method to improve the accuracy
of estimated optimal cutpoint and it’s significance under competing risks. Simulation results
indicated the adequacy of our method using the proposed statistics, which was illustrated
with a real dataset from NSABP B-14 study to estimate an optimal cutpoint of age and
estrogen receptor level.
Second study was to develop a residual life regression model for competing risks. This
regression model associates the quantile residual life times with important covariates at a
given time point under a competing risks setting. A vector of covariates was regressed on the
conditional cause-specific quantile residual life function, which can be obtained by inverting
the cause-specific residual cumulative incidence function. The proposed inference method
for the effects of prognostic factors does not involve estimation of the improper probability
density function of the cause-specific residual life distribution under competing risks. Simu-
lation studies showed that the proposed estimation and test procedures have reasonable finite
sample properties. A real dataset from the NSABP B-04 study was reanalyzed for different
quantiles of τ = 0.1, 0.2, 0.3. The model can be a useful alternative to the subdistribution
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proportional hazards model by providing more detailed and clinically more relevant informa-
tion of covariate effects on the life expectancy at a given time point. The grid search method
used to minimize the estimating equation provided reasonable solutions in our simulation
studies and real examples. However, computational time of this method tends to increase
exponentially as more parameters are included in the model, proportional to increasing grid
points. A more efficient method to speed up the optimization procedure and to reduce the
computational cost might promote the practicability of our proposed method for the data
with manifold covariates in the future.
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APPENDIX A
CONSISTENCY OF βˆ1,t0|τ
Assume that the covariate vector Z is uniformly bounded and suppose that the true value
β01,t0|τ of β1,t0|τ is in the interior of a bounded convex region D. Define
S˜1,t0|τ,n(β1,t0|τ ) =
n∑
i=1
[
F1{t0 + exp(β′1,t0|τZi)|Zi} − F1(t0|Zi)− τP (Ti ≥ t0|Zi)
]
Zi,
which reduces to 0 when β1,t0|τ = β
0
1,t0|τ . From Cso¨rgo¨ and Hova´rth (1983) [6], for all  > 0,
sup |Gˆ(s)−G(s)| = o(n−1/2+), a.s.,
which can be used to show that for β1,t0|τ ∈ D,
S1,t0|τ,n(β1,t0|τ )− S˜1,t0|τ,n(β1,t0|τ ) =
n∑
i=1
[G−1(Yi)[[I{Yi ≤ t0 + exp(β′1,t0|τZi)} − I(Yi ≤ t0)]I(δi = 1)
− Pr(Yi ≤ t0 + exp(β1,t0|τZi), δi = 1|Zi)− Pr(Yi ≤ t0, δi = 1|Zi)]
− τG−1(t0){I(Yi ≥ t0)− Pr(Yi ≥ t0|Zi)}]Zi + o(n1/2+), a.s.
Since
sup
β1,t0|τ∈D
|
n∑
i=1
G−1(Yi)[[I{Yi ≤ t0 + exp(β′1,t0|τZi)} − I(Yi ≤ t0)]I(δi = 1)
−Pr(Yi ≤ t0 + exp(β′1,t0|τZi), δi = 1|Zi)− Pr(Yi ≤ t0, δi = 1|Zi)]| = o(n1/2+)
and
sup
β1,t0|τ∈D
|
n∑
i=1
G−1(t0){I(Yi ≥ t0)− P (Yi ≥ t0|Zi)}| = o(n1/2+),
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then
sup
β1,t0|τ∈D
||n−1S1,t0|τ,n(β1,t0|τ )− n−1S˜1,t0|τ,n(β1,t0|τ )|| = o(n−1/2+), a.s. (A.1)
Suppose that matrix E [ZZ ′f(0|Z)] is positive definite, where f(.|Z) denotes the conditional
density of T given Z = z. By defining An(β) = (1/n)(∂/∂β)S˜1,t0|τ,n(β), An(β1,t0|τ ) is non-
positive definite, and An(β
0
1,t0|τ ) → −E [ZZ ′f(0|Z)], with probability 1, which is negative
definite. By Taylor series expansion around β0, we have
n−1{S˜1,t0|τ,n(βˆ1,t0|τ )− S˜1,t0|τ,n(β01,t0|τ )} ≈ (βˆ1,t0|τ − β01,t0|τ )′An(β∗t0), (A.2)
where β∗t0 is some point between βˆ1,t0|τ and β
0
1,t0|τ . Because n
−1S1,t0|τ,n(βˆ1,t0|τ ) = 0 by the
definition of βˆ1,t0|τ , from (A.1) n
−1S˜1,t0|τ,n(βˆ1,t0|τ ) → 0, a.s. as n → ∞. This coupled with
(A.2), implies that βˆ1,t0|τ → β01,t0|τ , as n→∞.
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APPENDIX B
ASYMPTOTIC NORMALITY OF N−1/2S1,T0|τ,N(β
0
1,t0|τ )
To show asymptotic normality, we approximate n−1/2S1,t0|τ,n(β
0
1,t0|τ ) by a sum of independent
zero-mean random variables. By definition, n−1/2S1,t0|τ,n(β
0
1,t0|τ ) can be approximated by
n−1/2
n∑
i=1
[{
I{Yi ≤ t0 + exp(β0′1,t0|τZi)} − I(Yi ≤ t0)
G(Yi)
}
I(δi = 1)− τ I(Yi ≥ t0)
G(t0)
]
Zi
−n−1/2
n∑
i=1
Zi
[
I{Yi ≤ t0 + exp(β0′1,t0|τZi)} − I(Yi ≤ t0)
]
I(δi = 1)
[
Gˆ(Yi)−G(Yi)
Gˆ(Yi)G(Yi)
]
+n−1/2τ
{
Gˆ(Yi)−G(Yi)
Gˆ(Yi)G(Yi)
}
n∑
i=1
ZiI(Yi ≥ t0) (B.1)
Define
Q1(s) = n
−1
n∑
i=1
Zi
[
I(t0 + exp(β
0′
1,t0|τZi)) ≥ min(s, Yi)− I(t0 ≥ min(s, Yi))
]
I(δi = 1),
then the second term in (B.1) is asymptotically equivalent to
−
∫ ∞
∞
[
n1/2{Gˆ(Yi)−G(Yi)}
G(s)2
]
dq1(s),
where q1(.) = limn→∞Q1(.). Applying martingale integral representation, −n1/2{Gˆ(s) −
G(s)}/G(s) can be represented as∫ s
−∞
n−1/2
∑n
i=1{dI(Yi ≤ v, δi = 0)− I(Yi ≥ v)dΛG(v)}
n−1
∑n
i=1 I(Yi ≥ v)
, (B.2)
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where ΛG(.) is the cumulative hazard function for the censoring variable. Then (B.2) is
asymptotically equal to
∫ s
−∞
h−1(v)n−1/2
n∑
i=1
{dI(Yi ≤ v, δi = 0)− I(Yi ≥ v)dΛG(v)}
where h(v) = limn→∞
∑n
i=1 I(Yi ≥ v)/n. Therefore the second term of (B.1) is asymptoti-
cally equal to
∫ ∞
−∞
G−1(s)
∫ s
−∞
h−1(v)n−1/2
n∑
i=1
{dI(Yi ≤ v, δi = 0)− I(Yi ≥ v)ΛG(v)}dq1(s).
The third term of (B.1) also can be represented in a similar way as
q2(t0)n
1/2
{
Gˆ(t0)−G(t0)
G(t0)
}
= −q2(t0)
∫ t0
−∞
h−1(v)n−1/2
n∑
i=1
{dI(Yi ≤ v, δi = 0)− I(Yi ≥ v)dΛG(v)} ,
where q2(t0) = limn→∞Q2(t0), and Q2(t0) = (τ/n)G(t0)−1
∑n
i=1 I(Yi ≥ t0)Zi. Finally (B.1)
is asymptotically equivalent to n−1/2
∑n
i=1 ξ1,t0|τ,i where
ξ1,t0|τ,i =
[
{I(Yi ≤ t0 + exp(βˆ1,t0|τZi))− I(Yi ≤ t0)}I(δi = 1)
G(Yi)
− τ I(Yi ≥ t0)
G(t0)
]
Zi
+
∫ ∞
−∞
G−1(s)
∫ s
−∞
h−1(v){dI(Yi ≤ v, δi = 0)− I(Yi ≥ v)dΛG(v)}dq1(s)
−q2(t0)
∫ t0
−∞
h−1(s){dI(Yi ≤ s, δi = 0)− I(Yi ≥ s)dΛG(s)}
Since ξ1,t0|τ,i, i = 1, ..., n, are independent random vectors with mean 0, the distribu-
tion of n−1/2S1,t0|τ,n(β
0
1,t0|τ ) is asymptotically normal with mean 0 and variance-covariance
matrix Γ1,t0|τ = n
−1∑n
i=1 ξ1,t0|τ,i ξ
′
1,t0|τ,i by Multivariate Central Limit Theorem. A con-
sistent estimate Γˆ1,t0|τ for the limiting covariance matrix of n
−1/2S1,t0|τ,n(β
0
1,t0|τ ) can be ob-
tained by substituting β01,t0|τ , G, h(s), q1(s), q2(t0), and dΛG(s) for βˆ1,t0|τ , Gˆ,
∑n
i=1 I(Yi ≥
s)/n, Q1(s), Q2(t0), and {
∑n
i=1 I(Yi ≥ s)}−1d{
∑n
i=1 I(Yi ≤ s, δi = 0)}, respectively. That
is,
Γˆ1,t0|τ = n
−1
n∑
i=1
ξˆ1,t0|τ,i ξˆ
′
1,t0|τ,i
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where
ξˆ1,t0|τ,i =

[
I{Yi ≤ t0 + exp(βˆ1,t0|τZi)} − I(Yi ≤ t0)
]
I(δi = 1)
Gˆ(Yi)
− τ I(Yi ≥ t0)
Gˆ(t0)
Zi
+
n∑
l=1
Zl
[
I{Yl ≤ t0 + exp(βˆ1,t0|τZl)} − I(Yl ≤ t0)
]
I(δl = 1)
Gˆ(Yl)

I(δi = 0)I{Yi ≤ t0 + exp(βˆ1,t0|τZl)}∑n
m=1 I(Ym ≥ Yi)
−
n∑
j=1
I(δj = 0)I
[
Yj ≤ min{t0 + exp(βˆ1,t0|τZl), Yj}
]
∑n
m=1 I(Ym ≥ Yj)2

−
n∑
l=1
{
Zl
τI(Yl ≥ t0)
nGˆ(t0)
}[
I(δi = 0)I(Yi ≤ t0)∑n
m=1 I(Ym ≥ Yi)
−
n∑
j=1
I(δj = 0)I{Yj ≤ min(t0, Yi)}∑n
m=1 I(Ym ≥ Yj)}2
]
.
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